Thinking outside the embryo
Since 2001, when a federal funding freeze crippled research into the use of human embryonic stem cells to treat a host of congenital and degenerative conditions, molecular biologists have searched for a viable alternative. Now, they may have found a way. By reprogramming adult skin cells, researchers have produced stem cells that bypass the political and ethical stumbling blocks. But all is not perfect. In recent studies, the cells produced tumors in mice. Guest: Dr. George Daley, associate director of the Stem Cell Program, Children’s Hospital Boston.
At The World, we believe strongly that human-centered journalism is at the heart of an informed public and a strong democracy. We see democracy and journalism as two sides of the same coin. If you care about one, it is imperative to care about the other.
Every day, our nonprofit newsroom seeks to inform and empower listeners and hold the powerful accountable. Neither would be possible without the support of listeners like you. If you believe in our work, will you give today? We need your help now more than ever!